Abstract
Purpose Age-related macular degeneration (AMD) is a leading cause of blindness in the developed world. One of the most genetically well-characterized degenerative diseases, genome-wide association studies (GWAS) have identified 52 independent common or rare AMD risk associated variants. While transcriptome-wide association analyses (TWAS) and expression quantitative trait loci (eQTL) efforts have characterized the effects of these AMD-associated genes on mRNA expression in retinal tissue, we aimed to characterize the AMD-associated transcriptional profiles of functionally distinct ocular tissues including the macular and extramacular regions of the retina and the retinal-pigment epithelium (RPE)/choroid.
Methods Using publicly available microarray data (NCBI GEO accession: GSE29801) comprised of retinal and RPE/choroidal tissue samples from 142 AMD patients and 151 healthy individuals (118 retina and 175 RPE/Choroid samples), tissue-specific differential gene expression analyses were conducted. Transcriptome analyses were focused on 878 genes surrounding known AMD-associated loci.
Results Many genes which contain clinically significant or causal variants identified via GWAS or TWAS/eQTL studies were significantly differentially expressed and display transcriptional heterogeneity across different subtypes of ocular tissue and retinal geography in AMD-associated tissues.
Conclusion These findings demonstrate the importance of spatial heterogeneity and tissue specificity in the mRNA expression of known AMD-associated genes. Genes known to harbor rare or causal AMD- associated variants are differentially expressed in functionally distinct ocular tissues of AMD patients, suggesting they might contribute to disease regardless of mutation status.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the National Eye Institute's Predoctoral Eye & Vision Genomics Training Grant, T32-EY022303. The authors would like to thank the volunteers and patients who participated in the multiple studies from which publicly available microarray and any clinically associated metadata was derived.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Written consent was obtained from all participants or their surviving relatives under protocols which adhered to the guidelines described by the Declaration of Helsinki, as previously described. This previous study was approved by the St. Louis University, the University of Iowa, the University of Utah, and the University of California, Santa Barbara institutional review boards. Previous study: Newman AM, Gallo NB, Hancox LS, et al. Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks. Genome Med. 2012;4(2):16. doi:10.1186/gm315
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Financial support This work was supported by the National Eye Institute’s Predoctoral Eye & Vision Genomics Training Grant, T32-EY022303.
Conflicts of interest None of the authors have any proprietary interests or conflicts of interest related to this submission.
Data Availability
All data used to support the findings of this study are publicly available in NCBIs Gene Expression Omnibus (GEO), accession GSE29801, at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE29801
